This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Asia
BPI Asia 2024 is returning to Japan on October 21-23, 2024
Westin Miyako KyotoKyoto, Japan

Takashi Kaminagayoshi
Head of Biotherapeutics Process Development - Japan at Takeda Pharmaceutical Company Limited, Japan


With two decades of expertise in device development, including bioreactors, process engineering, and project management at Hitachi, I've been involved in numerous pharmaceutical facility projects globally for high potency drug substances and biologics. Joining Takeda in 2010, I led the pioneering GMP manufacturing of therapeutic antibodies in Japan at production scale. Focused on integrating cutting-edge technologies to optimize biologics processes, I hold a Ph.D. in Life Science and an MBA (MOT) from Yamaguchi University, complemented by a JDLA Deep Learning for GENERAL Certificate. Additionally, I proudly serve as the Biopharmaceutical COP Leader of ISPE Japan Affiliate.